Warning: The NCBI web site requires JavaScript to function. more...
Computational analysis of binding between malarial dihydrofolate reductases and anti-folates.
Choowongkomon K, Theppabutr S, Songtawee N, Day NP, White NJ, Woodrow CJ, Imwong M.
Malar J. 2010 Mar 2;9:65.
Related citations
An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210.
Gaffar FR, Wilschut K, Franssen FF, de Vries E.
Mol Biochem Parasitol. 2004 Feb;133(2):209-19.
Analysis of the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene sequence.
Eldin de Pécoulas P, Basco LK, Tahar R, Ouatas T, Mazabraud A.
Gene. 1998 Apr 28;211(1):177-85.
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.
Hastings MD, Sibley CH.
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13137-41. Epub 2002 Aug 27.
Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
Alam MT, Bora H, Bharti PK, Saifi MA, Das MK, Dev V, Kumar A, Singh N, Dash AP, Das B, Wajihullah, Sharma YD.
Antimicrob Agents Chemother. 2007 Mar;51(3):857-63. Epub 2006 Dec 28.
Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure.
Imwong M, Pukrittayakamee S, Rénia L, Letourneur F, Charlieu JP, Leartsakulpanich U, Looareesuwan S, White NJ, Snounou G.
Antimicrob Agents Chemother. 2003 May;47(5):1514-21.
Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system.
Hastings MD, Maguire JD, Bangs MJ, Zimmerman PA, Reeder JC, Baird JK, Sibley CH.
Antimicrob Agents Chemother. 2005 Feb;49(2):733-40.
Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli.
Tahar R, de Pécoulas PE, Basco LK, Chiadmi M, Mazabraud A.
Mol Biochem Parasitol. 2001 Apr 6;113(2):241-9.
Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.
Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrell R, Lowe G, Thebtaranonth Y, Yuthavong Y.
Bioorg Med Chem. 2000 May;8(5):1117-28.
Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
Somsak V, Uthaipibull C, Prommana P, Srichairatanakool S, Yuthavong Y, Kamchonwongpaisan S.
Malar J. 2011 Oct 7;10:291.
Molecular surveillance of Plasmodium vivax dhfr and dhps mutations in isolates from Afghanistan.
Zakeri S, Afsharpad M, Ghasemi F, Raeisi A, Safi N, Butt W, Atta H, Djadid ND.
Malar J. 2010 Mar 14;9:75.
Modeling the inhibition of quadruple mutant Plasmodium falciparum dihydrofolate reductase by pyrimethamine derivatives.
Fogel GB, Cheung M, Pittman E, Hecht D.
J Comput Aided Mol Des. 2008 Jan;22(1):29-38. Epub 2007 Dec 11.
Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
Leartsakulpanich U, Imwong M, Pukrittayakamee S, White NJ, Snounou G, Sirawaraporn W, Yuthavong Y.
Mol Biochem Parasitol. 2002 Jan;119(1):63-73.
Insights into antifolate resistance from malarial DHFR-TS structures.
Yuvaniyama J, Chitnumsub P, Kamchonwongpaisan S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw MD, Yuthavong Y.
Nat Struct Biol. 2003 May;10(5):357-65.
Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: structural basis for antifolate resistance and development of effective inhibitors.
Yuthavong Y, Yuvaniyama J, Chitnumsub P, Vanichtanankul J, Chusacultanachai S, Tarnchompoo B, Vilaivan T, Kamchonwongpaisan S.
Parasitology. 2005 Mar;130(Pt 3):249-59. Review.
Homology modeling of wild type and pyrimethamine/cycloguanil-cross resistant mutant type Plasmodium falciparum dihydrofolate reductase. A model for antimalarial chemotherapy resistance.
Santos-Filho OA, de Alencastro RB, Figueroa-Villar JD.
Biophys Chem. 2001 Jul 24;91(3):305-17.
Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates.
Imwong M, Pukrittakayamee S, Looareesuwan S, Pasvol G, Poirreiz J, White NJ, Snounou G.
Antimicrob Agents Chemother. 2001 Nov;45(11):3122-7.
Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
Fohl LM, Roos DS.
Mol Microbiol. 2003 Nov;50(4):1319-27.
Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK, Ringwald P.
Am J Trop Med Hyg. 2000 Feb;62(2):271-6.
Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent.
Kaur S, Prajapati SK, Kalyanaraman K, Mohmmed A, Joshi H, Chauhan VS.
Acta Trop. 2006 Feb;97(2):174-80. Epub 2005 Nov 23.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on